537-545
Review Article
The pharmacological treatment of opioid addiction—a clinical perspective
Philipp Lobmaier, Michael Gossop, Helge Waal and Jorgen Bramness
547-554
Review Article
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review
Sabrina Crépin, Marie-Laure Laroche, Bernard Sarry and Louis Merle
555-561
Clinical Trial
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)
Robert M. Ward, Brinda Tammara, Sandra E. Sullivan, Dan L. Stewart and Natalie Rath, et al.
563-569
Pharmacodynamics
Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers
Yongqing Wang, Hongwen Zhang, Ling Meng, Meifeng Wang and Hongyu Yuan, et al.
571-578
Pharmacogenetics
In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population
Natasa Djordjevic, Juan Antonio Carrillo, Guillermo Gervasini, Slobodan Jankovic and Eleni Aklillu
579-590
Pharmacogenetics
Open AccessExplaining variability in ciclosporin exposure in adult kidney transplant recipients
Rogier R. Press, Bart A. Ploeger, Jan den Hartigh, T. van der Straaten and Hans van Pelt, et al.
591-598
Pharmacogenetics
VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement
Helene Puehringer, Ralph M. Loreth, Gudrun Klose, Brigitte Schreyer and Walter Krugluger, et al.
599-604
Pharmacokinetics and Disposition
Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies
Juan José Torrado, María Blanco, Magí Farré, Pere Roset and Alfredo García-Arieta
605-610
Pharmacokinetics and Disposition
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?
Eloni T. Rotta, Sérgio L. Amantéa, Pedro E. Froehlich and Adriana Becker
611-617
Pharmacokinetics and Disposition
Open AccessPharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
Jan Gerard Maring, Floris M. Wachters, Monique Slijfer, J. Marina Maurer and H. Marike Boezen, et al.
619-625
Pharmacoepidemiology and Prescription
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study
Bjorn Gudbjornsson, Sigurdur B. Thorsteinsson, Helgi Sigvaldason, Rannveig Einarsdottir and Magnus Johannsson, et al.
627-632
Pharmacoepidemiology and Prescription
A pilot study to evaluate a community pharmacy–based monitoring system to identify adverse drug reactions associated with paediatric medicines use
Mansour Tobaiqy, Derek Stewart, Peter J. Helms, Christine Bond and Amanda Jane Lee, et al.
633-641
Pharmacoepidemiology and Prescription
Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol
Belen Ruiz-Antorán, Antònia Agustí Escasany, Antoni Vallano Ferraz, Imma Danés Carreras and Neus Riba, et al.
643-644
Letter to the Editors
Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke
Áine Merwick, Niamh Hannon, Peter J. Kelly and Killian O’Rourke
645-646
Letter to the Editors
Very late relapse of dapsone-induced methaemoglobinemia
Guillaume Moulis, Haleh Bagheri, Jacques Saint Martory, Pascale Bernard and Jean-Louis Montastruc